Cơ Chế Tác Dụng :
Doxorubicin Transdrug(R) is an investigational drug to treat hepatocellular carcinoma (HCC), primary liver cancer.
Doxorubicin Transdrug® is a PIHCA polymer used in nanoparticular form containing the active cancer drug doxorubicin. This unique and proprietary technology was developed by Professor Patrick Couvreur of the School of Pharmacy at the University of Paris XI (CNRS) and a leading expert in the field of nanoparticles.
Chỉ Định :
Investigated for use/treatment in hepatocellular carcinoma.
Tương Tác Thuốc :
-
Telithromycin
Telithromycin may reduce clearance of Doxorubicin. Consider alternate therapy or monitor for changes in the therapeutic/adverse effects of Doxorubicin if Telithromycin is initiated, discontinued or dose changed.
-
Terbinafine
Terbinafine may reduce the metabolism and clearance of Doxorubicin. Consider alternate therapy or monitor for therapeutic/adverse effects of Doxorubicin if Terbinafine is initiated, discontinued or dose changed.